register free | resend password


Follow-on Biologics Market Prominent Vendors, Business Strategies, and Analysis

Follow-on biologics market is driven by medical advances in treatment for serious illnesses followed by rise in patient care and surge in medicine manufacture. In addition, surging demands for low cost biological drugs is stimulating the market growth.

ID: 1554763
recent pressrelease next pressrelease

(businesspress24) - The global follow-on biologics market is set to grow at a specified CAGR during the forecast period. Biologic medicines constitute significance in terms of patient illnesses. The medicines are grown out of living cells under laboratory conditions since these are hard to manufacture, complex and large. The production of biologics is also referred as production of reference products as it involves inheritance of complex biologics and exclusive details of manufacturing process.

Follow-on biologics market is driven by medical advances in treatment for serious illnesses followed by rise in patient care and surge in medicine manufacture. In addition, surging demands for low cost biological drugs is stimulating the market growth. Drug manufacturers are now producing generic biopharmaceuticals, however, pricing remains a big concern. Increase in costs of healthcare treatment, expensive form of drugs and rise in population is likely to stimulate the market growth. However, uncertainties on outcome effect by consumption of biologics and stringent regulations is more likely to disturb the market growth during the forecast period.

Follow-on biologics market is segmented by type comprising insulin, growth hormones, interferons, fertility hormones, fusion proteins and monoclonal antibodies. Application segment for the market comprises blood disorders, chronic and autoimmune diseases and oncology diseases.

Geographical segmentation for the market spans North America, South America, Europe, Asia-Pacific, Middle East and Africa. North America and Europe market is likely to grow at a higher rate due to rise in medical infrastructure and increase in activities pertaining to patient care. Increase in R&D activities for production of biosimilar & biologics drugs.

The key players profiled in the follow-on biologics market report are Allergan, Allozyne, Alteogen, Alvogen, Amarey Novamedical, AstaZeneca, Bionovis, Biosidus, Bioton, CCM Duopharma, CCL Pharmaceuticals, Celltrion, Chong Kun Dang, Centocor Ortho Biotech, CinnaGen, Compass Biotechnologies, Ranbaxy, Syngene Pharmaceutical, Takeda, Zenotech, Zheijan Huahai Pharmaceutical.



More information:
http://bit.ly/35CIgkI http://bit.ly/35pbnYJ http://bit.ly/2EoaqnS https:// http://bit.ly/2El8z2X http://bit.ly/2swNP5A http://bit.ly/36PedH5 http://bit.ly/2Eo7JTf



Keywords (optional):

follow, on-biologics-market, biotechnology, follow, on-biologics-industry, follow, on-biologics, biotechnology-market, biotechnology-industry,



Company information / Profile:

Million Insights, is a distributor of market research reports, published by premium publishers only. We have a comprehensive marketplace that will enable you to compare data points, before you make a purchase. Enabling informed buying is our motto and we strive hard to ensure that our clients get to browse through multiple samples, prior to an investment. Service flexibility & the fastest response time are two pillars, on which our business model is founded. Our market research report store includes in-depth reports, from across various industry verticals, such as healthcare, technology, chemicals, food & beverages, consumer goods, material science & automotive.

PressRelease by

Requests:

"Million Insights

Felton Office Plaza 6265 Highway 9 Felton, California 95018, United States

Phone: +1-408-610-2300

Toll Free: +1-866-831-4085

Email: sales(at)millioninsights.com"



PressContact / Agency:



published by: unnati_gade
print pressrelease  send to a friend  

Date: 12/16/2019 - 10:49
Language: English
News-ID 1554763
Character count: 3673
Kontakt-Informationen:
Firma: Million Insights
Ansprechpartner: Tom Clark Feedback to businesspress24.com about Pressrelease-id:
Stadt: Felton
Telefon: 14086102300

Meldungsart: Financial
Versandart: send
Freigabedatum: 16.12.2019
Comments:



Number of hits: 180

Linking-Tips:



Direct Link to this PressRelease:






We would appreciate a link in your News-, Press- or Partner-Site.

Comments on this PressRelease






All members: 9 438
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 53


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.